Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

HaloTag® Interchangeable Labeling Technology for Cell Imaging and Protein Capture

Georgyi V. Los1, Al Darzins1, Natasha Karassina1, Chad Zimprich1, Randall Learish1, Mark G. McDougall2, Lance P. Encell1, Rachel Friedman-Ohana1, Monika Wood1, Gediminas Vidugiris1, Kris Zimmerman1, Paul Otto1, Dieter H. Klaubert2, and Keith V. Wood1
1Promega Corporation, 2Promega Biosciences, Inc.
Publication Date: 2005


The HaloTag® Interchangeable Labeling Technology provides new options for rapid, site-specific labeling of proteins in living cells and in vitro. The technology is based on the formation of a covalent bond between the HaloTag® Protein and synthetic ligands that carry a variety of functionalities, including fluorescent labels, affinity tags and attachments to a solid phase. The covalent bond forms rapidly under physiological conditions, is highly specific and essentially irreversible, yielding a complex that is stable even under denaturing conditions. The ability to create labeled HaloTag® fusion proteins with a wide range of optical properties and functions allows researchers to image and localize labeled HaloTag®; protein fusions in live- or fixed-cell populations and isolate and analyze HaloTag® Protein fusions and protein complexes. This article presents data obtained using three commercially available ligands and one ligand that is currently under development.

Cell Notes 11, 2–6.

Related Products